Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Orthopaedic Surgery, University of California, San Francisco, CA, USA.
Eur J Hum Genet. 2020 Dec;28(12):1631-1644. doi: 10.1038/s41431-020-00725-5. Epub 2020 Sep 18.
Cascade testing is the process of offering genetic counseling and testing to at-risk relatives of an individual who has been diagnosed with a genetic condition. It is critical for increasing the identification rates of individuals with these conditions and the uptake of appropriate preventive health services. The process of cascade testing is highly varied in clinical practice, and a comprehensive understanding of factors that hinder or enhance its implementation is necessary to improve this process. We conducted a systematic review to identify barriers and facilitators for cascade testing and searched PubMed, CINAHL via EBSCO, Web of Science, EMBASE, and the Cochrane Library for articles published from the databases' inception to November 2018. Thirty articles met inclusion criteria. Barriers and facilitators identified from these studies at the individual-level were organized into the following categories: (1) demographics, (2) knowledge, (3) attitudes, beliefs, and emotional responses of the individual, and (4) perceptions of relatives, relatives' responses, and attitudes toward relatives. At the interpersonal-level, barriers and facilitators were categorized as (1) family communication-, support- and dynamics-, and (2) provider-factors. Finally, barriers at the environmental-level relating to accessibility of genetic services were also identified. Our findings suggest that several individual, interpersonal and environmental factors may play a role in cascade testing. Future studies to further investigate these barriers and facilitators are needed to inform future interventions for improving the implementation of cascade testing for genetic conditions in clinical practice.
级联检测是指对已被诊断出患有遗传疾病的个体的高危亲属进行遗传咨询和检测的过程。这对于提高这些疾病患者的识别率和接受适当预防保健服务的比例至关重要。在临床实践中,级联检测的过程差异很大,因此需要全面了解阻碍或促进其实施的因素,以改进这一过程。我们进行了一项系统评价,以确定级联检测的障碍和促进因素,并在 PubMed、CINAHL via EBSCO、Web of Science、EMBASE 和 Cochrane Library 中搜索了从数据库创建到 2018 年 11 月发表的文章。有 30 篇文章符合纳入标准。从这些研究中确定的个体层面的障碍和促进因素分为以下几类:(1)人口统计学特征,(2)知识,(3)个体的态度、信念和情绪反应,以及(4)对亲属的看法、亲属的反应和对亲属的态度。在人际层面,障碍和促进因素分为(1)家庭沟通、支持和动态,以及(2)提供者因素。最后,还确定了与遗传服务可及性相关的环境层面的障碍。我们的研究结果表明,一些个体、人际和环境因素可能在级联检测中发挥作用。需要进一步研究这些障碍和促进因素,为改善遗传疾病临床实践中级联检测的实施提供信息。